Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 1/2
This trial is looking at using pazopanib and fosbretabulin together for women with ovarian cancer that has come back. It is for women who have
These cancers are treated in a similar way. When we use the term ovarian cancer in this summary, we are referring to all 3.
This trial is supported by Cancer Research UK.
Recruitment start: 17 September 2014
Recruitment end: 30 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Jayson
Professor Gordon Rustin
Cancer Research UK
Cancer Treatment and Research Trust (Mount Vernon Cancer Research)
Experimental Cancer Medicine Centre (ECMC)
Novartis
OXiGENE
The Christie NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/13/022.
Last reviewed: 29 Jun 2017
CRUK internal database number: 11230
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
